Phase 4 N=727 Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
Influenza
Primary: Microneutralization (MN) Assay Response to Cell-grown Influenza A/H3N2 - Seroconversion Rate (SCR) — 112; 48; 29 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=2,892 High Tech and High Touch (HT2): Transforming Patient Engagement Through Portal Technology at the Bedside
Physician-Patient Relations · Inpatient Facility Diagnoses · Electronic Health Records
Primary: Inpatient Portal Use Frequency — 29; 21; 29; 20 Inpatient portal sessions
N/A N=6 RIXUBIS Drug Use-Result Survey (Japan)
Hemophilia B
Primary: Number of Participants Who Discontinued the Use of Nonacog Gamma (Genetical Recombination) — 1 Participants
N/A N=30 Shoulder Instability in Children: Muscle Activity and Movement
Shoulder Injuries · Musculoskeletal Injury · Pediatric ALL
Primary: Number of Shoulder Instability Episodes (Subluxation and Dislocations)
N/A N=32 Randomized Clinical Trial on Transanal Irrigation
Low Anterior Resection Syndrome
Primary: LARS Score — 21.3; 32.2 score on a scale
N/A N=925 Comparison of Outcomes of Complex Abdominal Aortic Aneurysm Treatment
Juxtarenal Aortic Aneurysm · Pararenal Aneurysm
Primary: Aortic Related Reintervention. — 44; 63 Participants
Phase 3 N=1,030 A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
Prostate Cancer
Primary: Radiographic Progressive Free Survival (rPFS) Assessed by Blinded Independent Central Review (BICR) Per Prostate Cancer Working Group 3 (PCWG3) — 9.43; 8.74 months…
N/A N=3,086 COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II
Health Behavior · Health Care Utilization
Primary: Testing Barriers and Hesitancy — 0.29; 0.24 score on a scale — p=0.09
N/A N=129 Weight Loss Physical Disabilities
Physical Disability
Primary: Weight Change in kg From Baseline to 6-months — -6.23; -8.16 kg
N/A N=42 Attachment and Biobehavioral Catch-up for Depression
Depressive Symptoms · Anxiety Symptoms
Primary: Change From Baseline in Internalizing Subscale Score of the Child Behavior Checklist (CBCL) at Week 10 (Value at Baseline Minus Value at Post Intervention (Week 10))…
Phase 1 N=47 A Pharmacokinetic Study of Tedizolid Phosphate in Pediatric Participants With Gram-Positive Infections (MK-1986-014)
Gram-Positive Infections
Primary: Part A: Area Under the Concentration-time Curve From Time 0 to Time of Last Quantifiable Drug Concentration (AUC0-last) of Tedizolid Phosphate (Prodrug) After…
N/A N=36 Hydrogen Peroxide to the Wound Following Surgical Incision Affecting Cultures in Primary Shoulder Arthroplast
Primary Anatomic or Reverse Total Shoulder Arthroplasty
Primary: Number of Positive vs Negative Culture's Based on Skin Prep Method — 6; 6; 12; 11 Participants
N/A N=6 Cognitive Rehab for Parkinson's
Parkinson's Disease · Mild Cognitive Impairment
Primary: Change in NIH Sponsored Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research (NIH-EXAMINER) Executive Composite Score — 0.34; -.42…
N/A N=48 A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.
Breast Cancer
Primary: Number of Participants Classified According to Treatment Pattern — 30; NA; NA; NA Participants
Phase 2 N=74 Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans
Healthy
Primary: Change in C-terminal Telopeptide of Type I Collagen [CTX] — -4.1; 13.7; -7.7 percent change — p=0.611